speb/financial-data huggingface dataset:
AMRN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -7738000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Interest Income: 2783000.00
AMRN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -12129000.00
AMRN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2783000.00
AMRN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -248000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Net PPE: 7199000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 444828000.00
AMRN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 8576000.00
AMRN income_statement (quarterly, 2025-09-30) — Normalized Income: 1231023.78
AMRN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -12697000.00
AMRN income_statement (quarterly, 2025-09-30) — Operating Income: -1697000.00
AMRN income_statement (quarterly, 2025-09-30) — Operating Revenue: 49670000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 415965977.00
AMRN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 29434000.00
AMRN income_statement (quarterly, 2025-09-30) — Other Gand A: 12584000.00
AMRN income_statement (quarterly, 2025-09-30) — Other Income Expense: -9201000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 14066000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 10215000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 11956000.00
AMRN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 205000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Other Properties: 7199000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 163785000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Payables: 36712000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 182233000.00
AMRN income_statement (quarterly, 2025-09-30) — Pretax Income: -8115000.00
AMRN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -57000.00
AMRN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -69129000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Receivables: 127309000.00
AMRN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 27462000.00
AMRN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 867000.00
AMRN income_statement (quarterly, 2025-09-30) — Research And Development: 4208000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 301000.00
AMRN income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 9406000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1706120000.00
AMRN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1759000.00
AMRN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 57000000.00
AMRN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 5354000.00
AMRN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 19697000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Share Issued: 429597419.00
AMRN income_statement (quarterly, 2025-09-30) — Special Income Charges: -9406000.00
AMRN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1956000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 458894000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 444828000.00
AMRN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -436976.22
AMRN income_statement (quarterly, 2025-09-30) — Tax Provision: -377000.00
AMRN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.05
AMRN balance_sheet (quarterly, 2025-09-30) — Total Assets: 659814000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 458894000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Total Debt: 6731000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 458894000.00
AMRN income_statement (quarterly, 2025-09-30) — Total Expenses: 51367000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 200920000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 31480000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 18687000.00
AMRN income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -11103000.00
AMRN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -9406000.00
AMRN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -9406000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 13631442.00
AMRN balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 67356000.00
AMRN balance_sheet (quarterly, 2025-09-30) — Working Capital: 446101000.00
AMRN income_statement (annual, 2025-12-31) — +Operating Expense: 134809000.00
AMRN income_statement (quarterly, 2025-12-31) — +Operating Expense: 25430000.00
AMRN income_statement (annual, 2025-12-31) — +Total Revenue: 213646000.00
AMRN income_statement (quarterly, 2025-12-31) — +Total Revenue: 49219000.00
AMRN balance_sheet (annual, 2025-12-31) — Accounts Payable: 45355000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 45355000.00
AMRN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 126832000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 126832000.00
AMRN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1474000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1474000.00
AMRN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1923801000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1923801000.00
AMRN balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -18151000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -18151000.00
AMRN cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 3024000.00
AMRN cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 701000.00
AMRN cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 3024000.00
AMRN cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 701000.00
AMRN cash_flow (annual, 2025-12-31) — Amortization Of Securities: -3646000.00
AMRN cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -627000.00
AMRN income_statement (annual, 2025-12-31) — Basic Average Shares: 20749200.00
AMRN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 20800000.00
AMRN income_statement (annual, 2025-12-31) — Basic EPS: -1.80
AMRN income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
AMRN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 121338000.00
AMRN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 123103000.00
AMRN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 6080000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 6080000.00
AMRN balance_sheet (annual, 2025-12-31) — Capital Stock: 310184000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 310184000.00
AMRN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 134660000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 134660000.00
AMRN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 302589000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 302589000.00
AMRN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2034000.00
AMRN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4000.00
AMRN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 8829000.00
AMRN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3516000.00
AMRN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 6728000.00
AMRN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 15278000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Account Payable: 14510000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 12226000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Inventory: 34878000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2101000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 158000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 54000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1058000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -927000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Payable: 14510000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Payable: 12226000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 14510000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 12226000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -12456000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 4804000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Receivables: -3825000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 756000.00
AMRN cash_flow (annual, 2025-12-31) — Change In Working Capital: 32207000.00
AMRN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 14812000.00
AMRN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -4553000.00
AMRN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 477000.00
AMRN cash_flow (annual, 2025-12-31) — Changes In Cash: 13523000.00
AMRN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 11758000.00
AMRN balance_sheet (annual, 2025-12-31) — Common Stock: 310184000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Common Stock: 310184000.00
AMRN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 459281000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 459281000.00
AMRN income_statement (annual, 2025-12-31) — Cost Of Revenue: 92778000.00
AMRN income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 26050000.00
AMRN balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 130766000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 130766000.00
AMRN balance_sheet (annual, 2025-12-31) — Current Assets: 649882000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Current Assets: 649882000.00
AMRN balance_sheet (annual, 2025-12-31) — Current Liabilities: 194459000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 194459000.00
AMRN cash_flow (annual, 2025-12-31) — Depreciation: 4000.00
AMRN cash_flow (quarterly, 2025-12-31) — Depreciation: 1000.00
AMRN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3028000.00
AMRN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 702000.00
AMRN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3028000.00
AMRN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 702000.00
AMRN income_statement (annual, 2025-12-31) — Diluted Average Shares: 20749200.00
AMRN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 20800000.00
AMRN income_statement (annual, 2025-12-31) — Diluted EPS: -1.80
AMRN income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
AMRN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1224000.00
AMRN income_statement (annual, 2025-12-31) — EBIT: -36041000.00
AMRN income_statement (quarterly, 2025-12-31) — EBIT: -24361000.00
AMRN income_statement (annual, 2025-12-31) — EBITDA: -33013000.00
AMRN income_statement (quarterly, 2025-12-31) — EBITDA: -23659000.00
AMRN cash_flow (annual, 2025-12-31) — End Cash Position: 134861000.00
AMRN cash_flow (quarterly, 2025-12-31) — End Cash Position: 134861000.00
AMRN cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2034000.00
AMRN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4000.00
AMRN balance_sheet (annual, 2025-12-31) — Finished Goods: 75418000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Finished Goods: 75418000.00
AMRN cash_flow (annual, 2025-12-31) — Free Cash Flow: 6728000.00
AMRN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 15278000.00
AMRN income_statement (annual, 2025-12-31) — General And Administrative Expense: 74411000.00
AMRN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 16329000.00
AMRN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 13365000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 13365000.00
AMRN balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 144983000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 144983000.00
AMRN balance_sheet (annual, 2025-12-31) — Gross PPE: 7947000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7947000.00
AMRN income_statement (annual, 2025-12-31) — Gross Profit: 120868000.00
AMRN income_statement (quarterly, 2025-12-31) — Gross Profit: 23169000.00
AMRN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1000000.00
AMRN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 852000.00
AMRN income_statement (annual, 2025-12-31) — Interest Expense: 7000.00
AMRN income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 7000.00
AMRN income_statement (annual, 2025-12-31) — Interest Income: 10853000.00
AMRN income_statement (quarterly, 2025-12-31) — Interest Income: 2576000.00
AMRN income_statement (annual, 2025-12-31) — Interest Income Non Operating: 10853000.00
AMRN income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2576000.00
AMRN balance_sheet (annual, 2025-12-31) — Inventory: 195910000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Inventory: 195910000.00
AMRN balance_sheet (annual, 2025-12-31) — Invested Capital: 459281000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 459281000.00
AMRN cash_flow (annual, 2025-12-31) — Investing Cash Flow: 8829000.00
AMRN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -3516000.00
AMRN balance_sheet (annual, 2025-12-31) — Leases: 217000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Leases: 217000.00
AMRN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 6080000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 6080000.00
AMRN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6080000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6080000.00
AMRN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1269000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1269000.00
AMRN income_statement (annual, 2025-12-31) — Net Income: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Income: -1224000.00
AMRN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1224000.00
AMRN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1224000.00
AMRN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1224000.00
AMRN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1224000.00
AMRN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -38798000.00
AMRN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1224000.00
AMRN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -38798000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1224000.00
AMRN cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
AMRN income_statement (annual, 2025-12-31) — Net Interest Income: 10846000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Interest Income: 2569000.00
AMRN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 8829000.00
AMRN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -3516000.00
AMRN income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 10846000.00
AMRN income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 2569000.00
AMRN cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2174000.00
AMRN cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -87000.00
AMRN balance_sheet (annual, 2025-12-31) — Net PPE: 6473000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Net PPE: 6473000.00
AMRN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
AMRN balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 445916000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 445916000.00
AMRN income_statement (annual, 2025-12-31) — Normalized EBITDA: 3216000.00
AMRN income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -19595000.00
AMRN income_statement (annual, 2025-12-31) — Normalized Income: -10177090.00
AMRN income_statement (quarterly, 2025-12-31) — Normalized Income: 1986560.00
AMRN cash_flow (annual, 2025-12-31) — Operating Cash Flow: 6728000.00
AMRN cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 15278000.00
AMRN income_statement (annual, 2025-12-31) — Operating Income: -13941000.00
AMRN income_statement (quarterly, 2025-12-31) — Operating Income: -2261000.00
AMRN income_statement (annual, 2025-12-31) — Operating Revenue: 213646000.00
AMRN income_statement (quarterly, 2025-12-31) — Operating Revenue: 49219000.00
AMRN balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 416214102.00
AMRN balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 416214102.00
AMRN balance_sheet (annual, 2025-12-31) — Other Current Assets: 24350000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 24350000.00
AMRN balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 18338000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 18338000.00
AMRN income_statement (annual, 2025-12-31) — Other Gand A: 65167000.00
AMRN income_statement (quarterly, 2025-12-31) — Other Gand A: 15243000.00
AMRN income_statement (annual, 2025-12-31) — Other Income Expense: -32953000.00
AMRN income_statement (quarterly, 2025-12-31) — Other Income Expense: -1160000.00
AMRN balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 13365000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 13365000.00
AMRN balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1055000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1055000.00
AMRN balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 10955000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 10955000.00
AMRN income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3276000.00
AMRN income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 2904000.00
AMRN balance_sheet (annual, 2025-12-31) — Other Properties: 6461000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Properties: 6461000.00
AMRN balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 167929000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 167929000.00
AMRN balance_sheet (annual, 2025-12-31) — Payables: 45355000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Payables: 45355000.00
AMRN balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 176121000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 176121000.00
AMRN income_statement (annual, 2025-12-31) — Pretax Income: -36048000.00
AMRN income_statement (quarterly, 2025-12-31) — Pretax Income: -852000.00
AMRN cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 140000.00
AMRN cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 140000.00
AMRN balance_sheet (annual, 2025-12-31) — Properties: 0.00
AMRN balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
AMRN cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: 0.00
AMRN cash_flow (annual, 2025-12-31) — Purchase Of Investment: -200472000.00
AMRN cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -50517000.00
AMRN cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
AMRN balance_sheet (annual, 2025-12-31) — Raw Materials: 112291000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Raw Materials: 112291000.00
AMRN balance_sheet (annual, 2025-12-31) — Receivables: 126832000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Receivables: 126832000.00
AMRN income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 92778000.00
AMRN income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 26050000.00
AMRN income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3028000.00
AMRN income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 702000.00
AMRN income_statement (annual, 2025-12-31) — Research And Development: 19806000.00
AMRN income_statement (quarterly, 2025-12-31) — Research And Development: 5371000.00
AMRN balance_sheet (annual, 2025-12-31) — Restricted Cash: 201000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 201000.00
AMRN income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 36229000.00
AMRN income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 4064000.00
AMRN balance_sheet (annual, 2025-12-31) — Retained Earnings: -1707344000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1707344000.00
AMRN income_statement (annual, 2025-12-31) — Salaries And Wages: 9244000.00
AMRN income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1086000.00
AMRN cash_flow (annual, 2025-12-31) — Sale Of Investment: 209301000.00
AMRN cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 47001000.00
AMRN income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 40592000.00
AMRN income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 3730000.00
AMRN income_statement (annual, 2025-12-31) — Selling General And Administration: 115003000.00
AMRN income_statement (quarterly, 2025-12-31) — Selling General And Administration: 20059000.00
AMRN balance_sheet (annual, 2025-12-31) — Share Issued: 429847579.00
AMRN balance_sheet (quarterly, 2025-12-31) — Share Issued: 429847579.00
AMRN income_statement (annual, 2025-12-31) — Special Income Charges: -36229000.00
AMRN income_statement (quarterly, 2025-12-31) — Special Income Charges: -4064000.00
AMRN cash_flow (annual, 2025-12-31) — Stock Based Compensation: 13937000.00
AMRN cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1615000.00
AMRN balance_sheet (annual, 2025-12-31) — Stockholders Equity: 459281000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 459281000.00
AMRN balance_sheet (annual, 2025-12-31) — Tangible Book Value: 445916000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 445916000.00
AMRN income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -7608090.00
AMRN income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -853440.00
AMRN income_statement (annual, 2025-12-31) — Tax Provision: 2750000.00
AMRN income_statement (quarterly, 2025-12-31) — Tax Provision: 372000.00
AMRN income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
AMRN income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
AMRN balance_sheet (annual, 2025-12-31) — Total Assets: 670775000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Assets: 670775000.00
AMRN balance_sheet (annual, 2025-12-31) — Total Capitalization: 459281000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 459281000.00
AMRN balance_sheet (annual, 2025-12-31) — Total Debt: 6080000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Debt: 6080000.00
AMRN balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 459281000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 459281000.00
AMRN income_statement (annual, 2025-12-31) — Total Expenses: 227587000.00
AMRN income_statement (quarterly, 2025-12-31) — Total Expenses: 51480000.00
AMRN balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 211494000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 211494000.00
AMRN balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 20893000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 20893000.00
AMRN balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 17035000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 17035000.00
AMRN income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -50170000.00
AMRN income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -6325000.00
AMRN income_statement (annual, 2025-12-31) — Total Unusual Items: -36229000.00
AMRN income_statement (quarterly, 2025-12-31) — Total Unusual Items: -4064000.00
AMRN income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -36229000.00
AMRN income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -4064000.00
AMRN balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 13633477.00
AMRN balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 13633477.00
AMRN balance_sheet (annual, 2025-12-31) — Treasury Stock: 67360000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 67360000.00
AMRN balance_sheet (annual, 2025-12-31) — Work In Process: 8201000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Work In Process: 8201000.00
AMRN balance_sheet (annual, 2025-12-31) — Working Capital: 455423000.00
AMRN balance_sheet (quarterly, 2025-12-31) — Working Capital: 455423000.00
AMRN income_statement (quarterly, 2026-03-31) — +Operating Expense: 25780000.00
AMRN income_statement (quarterly, 2026-03-31) — +Total Revenue: 45132000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 48153000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 108051000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1922254000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -14988000.00
AMRN cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 637000.00
AMRN cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 637000.00
AMRN cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -532000.00
AMRN income_statement (quarterly, 2026-03-31) — Basic Average Shares: 20952700.00
AMRN income_statement (quarterly, 2026-03-31) — Basic EPS: -0.60
AMRN cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 134861000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 5585000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Capital Stock: 314062000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 131063000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 307822000.00
AMRN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1687000.00
AMRN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8298000.00
AMRN cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 6388000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -14815000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Inventory: 12325000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 56000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 123000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Payable: -14815000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -14815000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1970000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 18744000.00
AMRN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 14463000.00
AMRN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 18781000.00
AMRN cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3597000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Common Stock: 314062000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 449413000.00
AMRN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 27363000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 131491000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Current Assets: 626016000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 179644000.00
AMRN cash_flow (quarterly, 2026-03-31) — Depreciation: 1000.00
AMRN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 638000.00
AMRN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 638000.00
AMRN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 20952700.00
AMRN income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.60
AMRN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — EBIT: -8011000.00
AMRN income_statement (quarterly, 2026-03-31) — EBITDA: -7373000.00
AMRN cash_flow (quarterly, 2026-03-31) — End Cash Position: 131264000.00
AMRN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1687000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 55468000.00
AMRN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 6388000.00
AMRN income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 17227000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12728000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 123039000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6010000.00
AMRN income_statement (quarterly, 2026-03-31) — Gross Profit: 17769000.00
AMRN cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 2331000.00
AMRN income_statement (quarterly, 2026-03-31) — Interest Income: 2423000.00
AMRN income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2423000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Inventory: 183585000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 449413000.00
AMRN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -8298000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5585000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5585000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Income: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -10512000.00
AMRN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10512000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Interest Income: 2423000.00
AMRN cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -8298000.00
AMRN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 2423000.00
AMRN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1687000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Net PPE: 6010000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 436685000.00
AMRN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -4050000.00
AMRN income_statement (quarterly, 2026-03-31) — Normalized Income: -8518200.00
AMRN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 6388000.00
AMRN income_statement (quarterly, 2026-03-31) — Operating Income: -8011000.00
AMRN income_statement (quarterly, 2026-03-31) — Operating Revenue: 45132000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 419594602.00
AMRN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 26357000.00
AMRN income_statement (quarterly, 2026-03-31) — Other Gand A: 15497000.00
AMRN income_statement (quarterly, 2026-03-31) — Other Income Expense: -3135000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 12728000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1010000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 11122000.00
AMRN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 188000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Other Properties: 6010000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 176759000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Payables: 48153000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 179644000.00
AMRN income_statement (quarterly, 2026-03-31) — Pretax Income: -8723000.00
AMRN cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -50798000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Raw Materials: 116787000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Receivables: 108051000.00
AMRN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 27363000.00
AMRN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 638000.00
AMRN income_statement (quarterly, 2026-03-31) — Research And Development: 4665000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 201000.00
AMRN income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 3323000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1717856000.00
AMRN income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1730000.00
AMRN cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 42500000.00
AMRN income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3888000.00
AMRN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21115000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Share Issued: 435545639.00
AMRN income_statement (quarterly, 2026-03-31) — Special Income Charges: -3323000.00
AMRN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2331000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 449413000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 436685000.00
AMRN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -1329200.00
AMRN income_statement (quarterly, 2026-03-31) — Tax Provision: 1789000.00
AMRN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
AMRN balance_sheet (quarterly, 2026-03-31) — Total Assets: 645764000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 449413000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Total Debt: 5585000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 449413000.00
AMRN income_statement (quarterly, 2026-03-31) — Total Expenses: 53143000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 196351000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 19748000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 16707000.00
AMRN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -11334000.00
AMRN income_statement (quarterly, 2026-03-31) — Total Unusual Items: -3323000.00
AMRN income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -3323000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 15951037.00
AMRN balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 69047000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Work In Process: 11330000.00
AMRN balance_sheet (quarterly, 2026-03-31) — Working Capital: 446372000.00
AMRQ.L income_statement (annual, 2021-12-31) — +Operating Expense: 23983253.00
AMRQ.L income_statement (annual, 2021-12-31) — +Total Revenue: 0.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Accounts Payable: 2049249.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -937020.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 3300723.00
AMRQ.L income_statement (annual, 2021-12-31) — Basic Average Shares: 177098737.00
AMRQ.L income_statement (annual, 2021-12-31) — Basic EPS: -0.14
AMRQ.L cash_flow (annual, 2021-12-31) — Beginning Cash Position: 61874999.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 841080.00
AMRQ.L cash_flow (annual, 2021-12-31) — Capital Expenditure: -11875926.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 763913.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Capital Stock: 88500205.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 27324459.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 27324459.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Cash Financial: 27324459.00
AMRQ.L cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: -65900.00
AMRQ.L cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -11875926.00
AMRQ.L cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: -22289316.00
AMRQ.L cash_flow (annual, 2021-12-31) — Change In Account Payable: 1141384.00
AMRQ.L cash_flow (annual, 2021-12-31) — Change In Payable: 1141384.00
AMRQ.L cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 1141384.00
AMRQ.L cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: 104641.00
AMRQ.L cash_flow (annual, 2021-12-31) — Change In Receivables: 11500.00
AMRQ.L cash_flow (annual, 2021-12-31) — Change In Working Capital: 1257525.00
AMRQ.L cash_flow (annual, 2021-12-31) — Changes In Cash: -34231142.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Common Stock: 88500205.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Common Stock Equity: 39968502.00
AMRQ.L cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Construction In Progress: 7452668.00
AMRQ.L income_statement (annual, 2021-12-31) — Cost Of Revenue: 90182.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Current Assets: 27642326.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 50835.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 50835.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Current Liabilities: 2100084.00
AMRQ.L cash_flow (annual, 2021-12-31) — Depreciation: 389953.00
AMRQ.L cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 389953.00
AMRQ.L income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 90182.00
AMRQ.L cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 389953.00
AMRQ.L income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 90182.00
AMRQ.L income_statement (annual, 2021-12-31) — Depreciation Income Statement: 90182.00
AMRQ.L income_statement (annual, 2021-12-31) — Diluted Average Shares: 177098737.00
AMRQ.L income_statement (annual, 2021-12-31) — Diluted EPS: -0.14
AMRQ.L income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — EBIT: -24649245.00
AMRQ.L income_statement (annual, 2021-12-31) — EBITDA: -24259292.00
AMRQ.L cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: -319398.00
AMRQ.L cash_flow (annual, 2021-12-31) — End Cash Position: 27324459.00
AMRQ.L cash_flow (annual, 2021-12-31) — Financing Cash Flow: -65900.00
AMRQ.L cash_flow (annual, 2021-12-31) — Free Cash Flow: -34165242.00
AMRQ.L cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
AMRQ.L income_statement (annual, 2021-12-31) — Gain On Sale Of Ppe: 0.00
AMRQ.L income_statement (annual, 2021-12-31) — Gain On Sale Of Security: -809751.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: -36772.00
AMRQ.L income_statement (annual, 2021-12-31) — General And Administrative Expense: 8821294.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Gross PPE: 15641916.00
AMRQ.L income_statement (annual, 2021-12-31) — Gross Profit: -90182.00
AMRQ.L income_statement (annual, 2021-12-31) — Insurance And Claims: 571364.00
AMRQ.L income_statement (annual, 2021-12-31) — Interest Expense: 39994.00
AMRQ.L income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 39994.00
AMRQ.L income_statement (annual, 2021-12-31) — Interest Income: 143759.00
AMRQ.L income_statement (annual, 2021-12-31) — Interest Income Non Operating: 143759.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Invested Capital: 39968502.00
AMRQ.L cash_flow (annual, 2021-12-31) — Investing Cash Flow: -11875926.00
AMRQ.L cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 713078.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 713078.00
AMRQ.L cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -65900.00
AMRQ.L cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 0.00
AMRQ.L cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 377674.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Income: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Income Common Stockholders: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: -24689239.00
AMRQ.L cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: -24689239.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Interest Income: 103765.00
AMRQ.L cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -65900.00
AMRQ.L cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -65900.00
AMRQ.L income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: 103765.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Net PPE: 14704896.00
AMRQ.L cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -11875926.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 39968502.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 9805.00
AMRQ.L income_statement (annual, 2021-12-31) — Normalized EBITDA: -23449541.00
AMRQ.L income_statement (annual, 2021-12-31) — Normalized Income: -23879488.00
AMRQ.L cash_flow (annual, 2021-12-31) — Operating Cash Flow: -22289316.00
AMRQ.L cash_flow (annual, 2021-12-31) — Operating Gains Losses: 377674.00
AMRQ.L income_statement (annual, 2021-12-31) — Operating Income: -23983253.00
AMRQ.L income_statement (annual, 2021-12-31) — Operating Revenue: 0.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 177098737.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: -36772.00
AMRQ.L income_statement (annual, 2021-12-31) — Other Gand A: 4593569.00
AMRQ.L income_statement (annual, 2021-12-31) — Other Income Expense: -809751.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 424637.00
AMRQ.L income_statement (annual, 2021-12-31) — Other Operating Expenses: 14280055.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Other Properties: 2556919.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Payables: 2049249.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 2049249.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Prepaid Assets: 266617.00
AMRQ.L income_statement (annual, 2021-12-31) — Pretax Income: -24689239.00
AMRQ.L cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
AMRQ.L cash_flow (annual, 2021-12-31) — Purchase Of PPE: -11875926.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Receivables: 51250.00
AMRQ.L income_statement (annual, 2021-12-31) — Reconciled Cost Of Revenue: 90182.00
AMRQ.L income_statement (annual, 2021-12-31) — Reconciled Depreciation: 389953.00
AMRQ.L cash_flow (annual, 2021-12-31) — Repayment Of Debt: -65900.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Retained Earnings: -51795654.00
AMRQ.L income_statement (annual, 2021-12-31) — Salaries And Wages: 3656361.00
AMRQ.L cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
AMRQ.L income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 791722.00
AMRQ.L income_statement (annual, 2021-12-31) — Selling General And Administration: 9613016.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Share Issued: 177098737.00
AMRQ.L income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
AMRQ.L cash_flow (annual, 2021-12-31) — Stock Based Compensation: 374771.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Stockholders Equity: 39968502.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Tangible Book Value: 39968502.00
AMRQ.L income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 0.00
AMRQ.L income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Taxes Receivable: 51250.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Assets: 42781664.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Capitalization: 39968502.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Debt: 763913.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 39968502.00
AMRQ.L income_statement (annual, 2021-12-31) — Total Expenses: 23983253.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 2813162.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 15139338.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 713078.00
AMRQ.L income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 24793004.00
AMRQ.L income_statement (annual, 2021-12-31) — Total Unusual Items: -809751.00
AMRQ.L income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -809751.00
AMRQ.L balance_sheet (annual, 2021-12-31) — Working Capital: 25542242.00
AMRQ.L income_statement (annual, 2022-12-31) — +Operating Expense: 22850546.00
AMRQ.L income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
AMRQ.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 1138961.00
AMRQ.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1617842.00
AMRQ.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 5250865.00
AMRQ.L income_statement (annual, 2022-12-31) — Basic Average Shares: 191575781.00
AMRQ.L income_statement (annual, 2022-12-31) — Basic EPS: -0.11
AMRQ.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 27324459.00
AMRQ.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 836200.00
AMRQ.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -325292.00
AMRQ.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 729237.00